HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Simplify Asset Management Inc.

Simplify Asset Management Inc. grew its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 67.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,351 shares of the company’s stock after purchasing an additional 944 shares during the quarter. Simplify Asset Management Inc.’s holdings in HCA Healthcare were worth $956,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in HCA. Terra Nova Asset Management LLC lifted its stake in HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after acquiring an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV lifted its stake in HCA Healthcare by 7.4% in the third quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after acquiring an additional 29 shares during the last quarter. Waldron Private Wealth LLC lifted its position in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after buying an additional 29 shares during the last quarter. Brookstone Capital Management lifted its position in shares of HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after buying an additional 30 shares during the last quarter. Finally, UMB Bank n.a. increased its holdings in shares of HCA Healthcare by 2.4% in the 3rd quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock valued at $529,000 after acquiring an additional 30 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,155 shares of company stock worth $5,608,990 over the last ninety days. 1.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

HCA has been the topic of a number of recent research reports. Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a report on Monday, August 19th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. KeyCorp dropped their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Finally, UBS Group boosted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Five analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $385.00.

HCA Healthcare Stock Down 2.3 %

Shares of HCA Healthcare stock traded down $8.10 on Friday, hitting $337.41. 685,304 shares of the company’s stock traded hands, compared to its average volume of 1,181,029. The stock has a market cap of $85.47 billion, a P/E ratio of 15.15, a PEG ratio of 1.34 and a beta of 1.68. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm’s 50-day moving average is $386.00 and its 200 day moving average is $357.03. HCA Healthcare, Inc. has a 52-week low of $238.82 and a 52-week high of $417.14.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.78%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.